跳至主要内容
临床试验/NL-OMON38644
NL-OMON38644撤回不适用

Prevention guidelines for contrast-induced nephropathy in contrast-enhanced CT: Appropriate and cost-effective? The Amsterdam, Maastricht, Alkmaar, Contrast Induced Nephropathy-Guideline study (the AMACING study) - The AMACING study

Academisch Medisch Centrum0 个研究点目标入组 2,000 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • All patients aged 18 years and above, scheduled to undergo elective contrast enhanced computed tomography (no emergency department or intensive care unit) with intravenous iodinated contrast material administration.
  • Patients with an indication for prophylactic intravenous hydration according to one of the Dutch CIN prevention guidelines will be eligible for randomization.
  • Indication is defined as: eGFR 30-44 ml/min/1.73m2; eGFR 45-59 ml/min/1.73m2 & diabetes mellitus or * 2 risk factors; Kahler*s disease (multiple myeloma) / Waldenström*s macroglobulinemia with small chain proteinuria. Risk factors include: age >75, anaemia, use of nephrotoxic medication, cardiac or peripheral vascular disease.

排除标准

  • Patients will only be included once in the RCT; no repeat inclusion for additional contrast enhanced CT examinations will occur.

研究者

相似试验